Announcements

Home > Investor Relations >Announcements
Back List
Announcement of securities acquiring information date : 2021/07/20

SEQ_NO

1

Date of announcement

2021/07/20

Time of announcement

16:20:44

Spokesman:

WANG,KUAN-CHIEH

Title of Spokesman:

Finance Manager

Subject

Announcement of securities acquiring information

To which item it meets

paragraph 20

Date of events

2021/07/20

Statement

1.Name of the securities:CHINA CHEMICAL & PHARMACEUTICAL CO., LTD.

2.Trading date:2021/06/01~2021/07/20

3.Amount, unit price, and total monetary amount of the transaction:

   Trading volume: 6,398,000 shares;

   Unit price: Average price NT$ 24.59per share;

   Total monetary amount: NT$ 157,343,521(including related

   taxes and expenses)

4.Gain (or loss) through disposal (not applicable in case of acquisition of

   securities):NA

5.Relationship with the underlying company of the trade:

   CCSB is the Company's investment using the equity method of accounting.

6.Current cumulative amount held, monetary amount, and shareholding

    percentage of cumulative holdings of the securities being traded (including

    the current trade), and status of any restriction of rights (e.g.pledges):

    Current cumulative volume38,497,137 shares

    AmountNT$779,407,974

    Shareholding percentage of holdings of the security being traded

    (including the current trade)12.91 %

     Status of any restriction of rightsNone

7.Current ratio of securities investment (including the current trade, as

    listed in article 3 of Regulations Governing the Acquisition and Disposal of

    Assets by Public Companies) to the total assets and equity attributable to

    owners of the parent as shown in the most recent financial statement and

    working capital as shown in the most recent financial statement as of the

    present:

    Ratio to the total assets: 29.23%

    Ratio to the shareholder's equity: 34.99 %

    Operational capital: NT$ 589,717 thousand

8.Concrete purpose of the acquisition or disposal:Investment

9.Any dissenting opinions of directors to the present transaction:No

10.Whether the counterparty of the current transaction is a related party:No

11.Trading counterparty and its relationship with the Company:NA

12.Date of the board of directors resolution:2020/11/27

13.Date of ratification by supervisors or approval by

      the audit committee:2020/11/27

14.Any other matters that need to be specified:None